Skip to main content
Top
Published in: BMC Gastroenterology 1/2005

Open Access 01-12-2005 | Research article

Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India

Authors: Sujoy Pal, Peush Sahni, Girish K Pande, Subrat K Acharya, Tushar K Chattopadhyay

Published in: BMC Gastroenterology | Issue 1/2005

Login to get access

Abstract

Background

Steroid-based intensive medical therapy for severe ulcerative colitis is successful in 60–70% of such patients. Patients with complications or those refractory to medical therapy require emergency colectomy for salvage. Little is known about the impact of timing of surgical intervention and surgical outcomes of such patients undergoing emergency surgery in India where the diagnosis is often delayed or missed in patients who are poor, malnourished and non-compliant to medical treatment.

Methods

The clinical records of all patients undergoing emergency surgery for severe ulcerative colitis or its complication in the Department of GI surgery AIIMS, New Delhi, India, between January 1985 and December 2003 were retrieved and data pertaining to demographic features, duration of intensive medical therapy, presence of complications, time from admission to emergency surgery, surgical procedure, in-hospital morbidity and mortality and follow up status extracted.

Results

A total of 72 patients underwent emergency surgery (Subtotal colectomy: 60; ileostomy alone under local anaesthesia: 12). Poor nutritional status was seen in 61% of the patients.
Twenty-one patients (29%) underwent emergency surgery for complications of severe ulcerative colitis such as colonic perforation (spontaneous 6, iatrogenic 4), massive lower gastrointestinal haemorrhage (5), toxic megacolon (4) and large bowel obstruction (2). The remaining patients (n = 51) underwent emergency surgery following failed intensive therapy; 17 underwent surgery ≤5 days (Group I) and 34 were operated >5 days (Group II) after initiation of intensive therapy. In this group all the post-operative deaths (n = 8) occurred in those who were operated after 5 days. The difference in mortality in these two groups (i.e. surgical intervention ≤ or >5 days) was statistically significant {0/17 (Group I) vs 8/34 (Group II); p = 0.03}.
Overall, 12 patients died (in-hospital mortality: 16.7%). The mortality was higher (10/43; 23.3%) in our early experience (i.e. 1985–1995) when compared to our subsequent experience (2/29; 6.9%) (1996–2003).
A total of 48 patients (including 3 awaiting a restorative procedure) are alive on follow up (66.7%; 3 patients lost to follow up). A restorative procedure could be successfully completed in 81% of the survivors of the emergency procedure.

Conclusion

To optimize the outcome, a combined team of physicians and surgeons should be involved in the management of patients with severe ulcerative colitis with focus on nutritional support, correction of metabolic derangements, close clinical monitoring and timely assessment for the need for emergency surgery. This retrospective analysis shows that improved results can be achieved with experience and by following a policy of early surgical intervention within 5 days, especially in patients who have failed intensive medical therapy.
Appendix
Available only for authorised users
Literature
2.
go back to reference Jewell DP: Ulcerative colitis. Chapter in: Sleisenger and Fordtran's Gastrointestinal and Liver disease. Edited by: Feldman M, Friedman LS, Sleisenger M. 2002, Saunders-Elsevier Science, Philadelphia, 2039-67. 7 Jewell DP: Ulcerative colitis. Chapter in: Sleisenger and Fordtran's Gastrointestinal and Liver disease. Edited by: Feldman M, Friedman LS, Sleisenger M. 2002, Saunders-Elsevier Science, Philadelphia, 2039-67. 7
4.
go back to reference Truelove SC, Jewell DP: Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet. 1974, 2: 1067-70. 10.1016/S0140-6736(74)90552-2.CrossRef Truelove SC, Jewell DP: Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet. 1974, 2: 1067-70. 10.1016/S0140-6736(74)90552-2.CrossRef
5.
go back to reference Jarnerot G, Rolny P, Sandberg-Gertzen H: Intensive intravenous treatment of ulcerative colitis. Gastroenterology. 1985, 85: 1005-13.CrossRef Jarnerot G, Rolny P, Sandberg-Gertzen H: Intensive intravenous treatment of ulcerative colitis. Gastroenterology. 1985, 85: 1005-13.CrossRef
6.
go back to reference Kornbluth A, Marion JF, Salomon P, Janowitz HD: How effective is current medical therapy for severe ulcerative and Crohn's colitis? An analytic review of selected trials. J Clin Gastroenterol. 1995, 20 (4): 280-4.CrossRefPubMed Kornbluth A, Marion JF, Salomon P, Janowitz HD: How effective is current medical therapy for severe ulcerative and Crohn's colitis? An analytic review of selected trials. J Clin Gastroenterol. 1995, 20 (4): 280-4.CrossRefPubMed
7.
go back to reference Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, Jewell DP: Predicting outcome in severe ulcerative colitis. Gut. 1996, 38 (6): 905-10.CrossRefPubMedPubMedCentral Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, Jewell DP: Predicting outcome in severe ulcerative colitis. Gut. 1996, 38 (6): 905-10.CrossRefPubMedPubMedCentral
8.
go back to reference Goligher JC, Hoffman DC, de Dombal FT: Surgical treatment of severe attacks of ulcerative colitis, with special reference to the advantages of early operation. Br Med J. 1970, 4 (737): 703-6.CrossRefPubMedPubMedCentral Goligher JC, Hoffman DC, de Dombal FT: Surgical treatment of severe attacks of ulcerative colitis, with special reference to the advantages of early operation. Br Med J. 1970, 4 (737): 703-6.CrossRefPubMedPubMedCentral
9.
go back to reference Hawley PR: Emergency surgery for ulcerative colitis. World J Surg. 1989, 12: 169-173. 10.1007/BF01658049.CrossRef Hawley PR: Emergency surgery for ulcerative colitis. World J Surg. 1989, 12: 169-173. 10.1007/BF01658049.CrossRef
10.
go back to reference Grotz RL, Pemberton JH: The ileal pouch operation for ulcerative colitis. Surg Clin North Am. 1993, 73 (5): 909-32.PubMed Grotz RL, Pemberton JH: The ileal pouch operation for ulcerative colitis. Surg Clin North Am. 1993, 73 (5): 909-32.PubMed
11.
go back to reference Farouk R, Pemberton JH: Surgical options in ulcerative colitis. Surg Clin North Am. 1997, 77 (1): 85-94. 10.1016/S0039-6109(05)70534-X.CrossRefPubMed Farouk R, Pemberton JH: Surgical options in ulcerative colitis. Surg Clin North Am. 1997, 77 (1): 85-94. 10.1016/S0039-6109(05)70534-X.CrossRefPubMed
12.
go back to reference Brooke BN, Sampson PA: An indication for surgery in acute ulcerative colitis. Lancet. 1964, 17: 1272-3. 10.1016/S0140-6736(64)92740-0.CrossRef Brooke BN, Sampson PA: An indication for surgery in acute ulcerative colitis. Lancet. 1964, 17: 1272-3. 10.1016/S0140-6736(64)92740-0.CrossRef
13.
go back to reference Veidenheimer MC: When should we operate on the patient with ulcerative colitis?. Surg Clin North Am. 1970, 50 (3): 743-8.PubMed Veidenheimer MC: When should we operate on the patient with ulcerative colitis?. Surg Clin North Am. 1970, 50 (3): 743-8.PubMed
14.
go back to reference Grant CS, Dozois RR: Toxic megacolon: ultimate fate of patients after successful medical management. Am J Surg. 1984, 147 (1): 106-10. 10.1016/0002-9610(84)90042-4.CrossRefPubMed Grant CS, Dozois RR: Toxic megacolon: ultimate fate of patients after successful medical management. Am J Surg. 1984, 147 (1): 106-10. 10.1016/0002-9610(84)90042-4.CrossRefPubMed
15.
go back to reference Becker JM: Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am. 1999, 28 (2): 371-90. 10.1016/S0889-8553(05)70061-3.CrossRefPubMed Becker JM: Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am. 1999, 28 (2): 371-90. 10.1016/S0889-8553(05)70061-3.CrossRefPubMed
16.
go back to reference Motson RW, Manche AR: Modified Hartmann procedure for acute ulcerative colitis. Surg Gynecol Obstet. 1985, 160 (5): 462-3.PubMed Motson RW, Manche AR: Modified Hartmann procedure for acute ulcerative colitis. Surg Gynecol Obstet. 1985, 160 (5): 462-3.PubMed
17.
go back to reference Katz JR: Medical and surgical management of severe colitis. Sem Gastrointest Dis. 2000, 11: 18-32. Katz JR: Medical and surgical management of severe colitis. Sem Gastrointest Dis. 2000, 11: 18-32.
18.
go back to reference Rombeau JL, Barot LR, Williamson CE, Mullen JL: Preoperative total parenteral nutrition and surgical outcome in patients with inflammatory bowel disease. Am J Surg. 1982, 143: 139-43. 10.1016/0002-9610(82)90144-1.CrossRefPubMed Rombeau JL, Barot LR, Williamson CE, Mullen JL: Preoperative total parenteral nutrition and surgical outcome in patients with inflammatory bowel disease. Am J Surg. 1982, 143: 139-43. 10.1016/0002-9610(82)90144-1.CrossRefPubMed
19.
go back to reference Truelove SC, Willoughby CP, Lee EG, Kettlewell MG: Further experience in the treatment of severe attacks of ulcerative colitis. Lancet. 1978, 2 (8099): 1086-8. 10.1016/S0140-6736(78)91816-0.CrossRefPubMed Truelove SC, Willoughby CP, Lee EG, Kettlewell MG: Further experience in the treatment of severe attacks of ulcerative colitis. Lancet. 1978, 2 (8099): 1086-8. 10.1016/S0140-6736(78)91816-0.CrossRefPubMed
20.
go back to reference Hyde GM, Jewell DP: Review article: the management of severe ulcerative colitis. Aliment Pharmacol Ther. 1997, 11 (3): 419-24. 10.1046/j.1365-2036.1997.00187.x.CrossRefPubMed Hyde GM, Jewell DP: Review article: the management of severe ulcerative colitis. Aliment Pharmacol Ther. 1997, 11 (3): 419-24. 10.1046/j.1365-2036.1997.00187.x.CrossRefPubMed
Metadata
Title
Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India
Authors
Sujoy Pal
Peush Sahni
Girish K Pande
Subrat K Acharya
Tushar K Chattopadhyay
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2005
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-5-39

Other articles of this Issue 1/2005

BMC Gastroenterology 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine